The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis

被引:125
作者
Daniels, GL
Faas, BHW
Green, CA
Smart, E
Maaskant-van Wijk, PA
Avent, ND
Zondervan, HA
von dem Borne, AEGK
van der Schoot, CE
机构
[1] Bristol Inst Transfus Med, Bristol BS10 5ND, Avon, England
[2] Int Blood Grp Reference Lab, Mol Genet Sect, Bristol, Avon, England
[3] Natal Blood Transfus Serv, Pinetown, South Africa
[4] Red Cross Blood Bank Rotterdam, Rotterdam, Netherlands
[5] Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Dept Expt Hematol, Amsterdam, Netherlands
[6] Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Dept Hematol, Amsterdam, Netherlands
[7] Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Immunocytol Lab, Amsterdam, Netherlands
[8] Univ Amsterdam, Expt & Clin Immunol Lab, Amsterdam, Netherlands
[9] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, NL-1105 AZ Amsterdam, Netherlands
[10] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1046/j.1537-2995.1998.381098440860.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: VS and V are common red cell antigens in persons of African origin. The molecular background of these Rh system antigens is poorly understood. STUDY DESIGN AND METHODS: Red cells from 100 black South Africans and 43 black persons from Amsterdam, the Netherlands, were typed serologically for various Rh system antigens. Allele-specific polymerase chain reaction and sequencing of polymerase chain reaction products were used to analyze C733G (Leu245Val) and G1006T (Gly336Cys) polymorphisms in exons 5 and 7 of RHCE and the presence of a D-CE hybrid exon 3. RESULTS: The respective frequencies of all VS+ and of VS+ V- (r'(s)) phenotypes were 43 percent and 9 percent in the South Africans and 49 percent and 12 percent in the Dutch donors. All VS+ donors had G733 (Val245), but six with G733 were VS- (4 V+(w), 2 V-). The four VS-V+(w) donors with G733 appeared to have a CE-D hybrid exon 5. T1006 (Cys336) was present in 12 percent and 16 percent of donors from the two populations. With only a few exceptions, T1006, a D-CE hybrid exon 3, and a C410T (Ala137Val) substitution were associated with a VS+ V- phenotype ((C)ce(s) or r'(s) haplotype). Two VS+ V- individuals, with the probable genotype, (C)ce(s)/ (C)ce(s), were homozygous for G733 and for T1006. CONCLUSIONS: It is likely that anti-VS and anti-V recognize the conformational changes created by Val245, but that anti-V is sensitive to additional conformational changes created by Cys336.
引用
收藏
页码:951 / 958
页数:8
相关论文
共 23 条
[1]  
Avent ND, 1997, BRIT J BIOMED SCI, V54, P16
[2]   Molecular analysis of Rh transcripts and polypeptides from individuals expressing the D-VI variant phenotype: An RHD gene deletion event does not generate all D(VI)ccEe phenotypes [J].
Avent, ND ;
Liu, W ;
Jones, JW ;
Scott, ML ;
Voak, D ;
Pisacka, M ;
Watt, J ;
Fletcher, A .
BLOOD, 1997, 89 (05) :1779-1786
[3]   Evidence of genetic diversity underlying Rh D-, weak D (D-u), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene [J].
Avent, ND ;
Martin, PG ;
ArmstrongFisher, SS ;
Liu, W ;
Finning, KM ;
Maddocks, D ;
Urbaniak, SJ .
BLOOD, 1997, 89 (07) :2568-2577
[4]   SEROTYPE SWITCHING IN A PARTIALLY DELETED RHD GENE [J].
BLUNT, T ;
DANIELS, G ;
CARRITT, B .
VOX SANGUINIS, 1994, 67 (04) :397-401
[5]  
CARTRON JP, 1995, BLOOD CEL B, V6, P189
[6]   Differences between RhD-negative Africans and RhD-negative Europeans [J].
Daniels, G ;
Green, C ;
Smart, E .
LANCET, 1997, 350 (9081) :862-863
[7]  
Daniels G., 1995, Human blood groups
[8]  
DENATALE A, 1955, JAMA-J AM MED ASSOC, V159, P247
[9]   Involvement of Ser103 of the Rh polypeptides in G epitope formation [J].
Faas, BHW ;
Beckers, EAM ;
Simsek, S ;
Overbeeke, MAM ;
Pepper, R ;
vanRhenen, DJ ;
vondemBorne, AEGK ;
vanderSchoot, CE .
TRANSFUSION, 1996, 36 (06) :506-511
[10]   Molecular background of VS and weak C expression in blacks [J].
Faas, BHW ;
Beckers, EAM ;
Wildoer, P ;
Ligthart, PC ;
Overbeeke, MAM ;
Zondervan, HA ;
vondemBorne, AEGK ;
vanderSchoot, CE .
TRANSFUSION, 1997, 37 (01) :38-44